LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Control Monitors Precision of Hemoglobin A1C Tests

By Labmedica staff writers
Posted on 08 Jan 2008
A liquid human whole blood-based third-party control monitors the precision of hemoglobin A1C tests on commonly used methods and instruments.

Known as the Liquichek Diabetes Control, it provides an unbiased assessment, helping to detect changes in assay performance and improving the quality of test results. Liquichek Diabetes Control is available in three levels with a 1 ml fill size. The Unity Interlaboratory Program, with peer group comparison, is available for use with Liquichek Diabetes Control, as well as Unity Real Time, a complete quality control (QC) data management software system designed to improve the effectiveness of quality control processes.

The Liquichek Diabetes Control is a newly available product from the Bio-Rad (Hercules, CA, USA) diabetes range of products. Bio-Rad Laboratories manufactures and distributes a broad range of products for the clinical diagnostic and life science research sectors. The company supplies hospitals, universities, major research institutions, as well as biotechnology and pharmaceutical companies worldwide.


Related Links:
Bio-Rad

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Serum Indices Control
Acusera Serum Indices Control
New
Microbiology Laboratory Automation Solution
BD Kiestra™ ReadA+BarcodA
New
Drug Testing Assays
Atellica DT 250 Analyzer

Latest Clinical Chem. News

Blood Test Could Guide Drug Selection to Prevent Repeat Heart Attacks and Strokes
08 Jan 2008  |   Clinical Chem.

Blood Test Patterns Improve Cancer Risk Assessment in Primary Care
08 Jan 2008  |   Clinical Chem.

Multi-Biomarker Blood Test Shows Promise for Early Pancreatic Cancer Detection
08 Jan 2008  |   Clinical Chem.